Pharma-Bio Serv Q3 revenue $4.8M, net income $0.3M down $2M YoY on SBA loan forgiveness

Pharma-Bio Serv, Inc.

Revenue for Q3 ended July 31, 2022: $4.8M, down $0.2M YoY; 9-month revenue $14.8M, up $0.2M.
Net income Q3: $0.3M vs. $2.3M prior year; prior year included $2.0M SBA loan forgiveness gain.
Repurchased 10,400 shares in Q3 and 81,303 in first nine months; 1,551,943 shares remain authorized.
CEO notes revenue growth in U.S. and European consulting markets, citing expansion opportunities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.